Peptide Science Semaglutide (Glp-1 Analogue) 3mg

Semaglutide is a GLP-1 (glucagon-like peptide-1) analogue that is used to manage type 2 diabetes and, more recently, for weight loss in people with obesity or overweight conditions. It mimics the action of the natural GLP-1 hormone in the body, which has several effects on glucose metabolism and appetite regulation.

Semaglutide works by:

1. Stimulating insulin secretion when blood sugar levels are elevated.
2. Inhibiting glucagon secretion, which prevents the liver from releasing too much glucose.
3. Slowing gastric emptying, which helps control appetite and promotes a feeling of fullness.
4. Reducing appetite, leading to weight loss.

Regarding the 3mg dose:

• For diabetes management, semaglutide is typically initiated at a lower dose (0.25 mg per week) and titrated up to a higher dose (up to 1 mg per week) to reduce side effects and achieve optimal control.
• For weight management (such as in the brand Wegovy), the usual target dose is 2.4 mg per week, and a 3 mg dose could be used as part of a clinical program, especially if titrating up from a lower dose.

This medication is typically delivered via subcutaneous injection, and the 3mg dose might be part of a step-up protocol as the body adjusts to the medication.

It’s essential to consult a healthcare provider before using semaglutide, especially at higher doses, to ensure it’s appropriate for your condition and to understand the risks and side effects.